Healthcare · Biotechnology
$2.49
+$0.03+1.22%
Delayed · · marketstack
all 10 open-market sales on file ran under a pre-arranged trading plan ($118K), so none was a decision taken that week. Who, and when
−$0.10−3.86%over 1M
Session
Day range100% of range
$2.45$2.49
Fundamentals
Visualize fundamentals and more- Market cap
- -
- P/E ratio
- -
Price ÷ trailing earnings
Revenue grew +161.14% in FY2025, +152.27% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.
Discussion
No comments yet
Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.
Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.
Updated · the last close
Compugen Ltd investor relations
What CGEN has filed with the SEC. This is not Compugen Ltd’s own investor relations site: these filings are the primary source that site publishes from.
Companies like Compugen Ltd
Also filed under Biotechnology, ranked by how closely they sit beside CGEN.
- MRNAModerna, Inc.compare with CGEN
- ROIVRoivant Sciences Ltd.compare with CGEN
- VRTXVertex Pharmaceuticals Inc. / MAcompare with CGEN
- XENE